Literature DB >> 17146179

Apoptosis of canine mammary tumor cells induced by small interfering RNA (siRNA) against Bcl-xL gene.

Fumito Tsuchiya1, Rui Kano, Junichi Sano, Keisuke Oguma, Atsuhiko Hasegawa.   

Abstract

The inhibition of Bcl-xL mRNA expression and the acceleration of apoptotic cell rates in canine mammary tumor cell line (CF33) by the small interfering RNA (siRNA) were analyzed. The level of Bcl-xL transcripts in CF33 was decreased when cultured with siRNA, suggesting that siRNA might inhibit the expression of Bcl-xL mRNA in the CF33. Apoptotic cell rates in CF33 cultured with siRNA in Oligofectamine medium, with double strand RNA in Oligofectamine medium, without siRNA in Oligofectamine medium and in DMEM alone were 60.9%, 30%, 28.7% and 11.6% at 48-hr incubation, respectively, when evaluated by TUNEL assay. From these results, it was suggested that canine Bcl-xL might be an anticancer target of canine tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146179     DOI: 10.1292/jvms.68.1199

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  A short splicing isoform of HBS1L links the cytoplasmic exosome and SKI complexes in humans.

Authors:  Katarzyna Kalisiak; Tomasz M Kuliński; Rafał Tomecki; Dominik Cysewski; Zbigniew Pietras; Aleksander Chlebowski; Katarzyna Kowalska; Andrzej Dziembowski
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

Review 2.  The Role of Bcl-xL Protein Research in Veterinary Oncology.

Authors:  Aleksandra Pawlak; Marta Henklewska
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.